Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
about
Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort StudyThe anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells.Prediction of therapy response in ovarian cancer: Where are we now?Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.Ang-1 and Ang-2 expression in angiomyolipoma and PEComa family tumors.Ang-2 but not Ang-1 expression in perivascular soft tissue tumors.MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of VE-cadherin expression.
P2860
Q33712746-96C93F20-60E5-4A6B-ABEB-C6DA67A84C9DQ33911286-6CC79875-A5AE-4E11-8633-08FED695941AQ39263260-2224AFFC-19C3-465A-B93F-9EBDD92FBDDBQ41258130-B1C2F3C4-F488-4799-AFCB-2E9EC636BCD5Q46174712-D320EAEB-D9E8-4D5C-AA94-0DB1D0916C0BQ46462894-03487005-21B3-4790-A9A4-1C676C7E0CD4Q51064283-8C9F1C1E-F3A0-451C-BFE9-80FF67855766
P2860
Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
@en
type
label
Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
@en
prefLabel
Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
@en
P2860
P1476
Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
@en
P2093
Khalid Al Wadi
Prafull Ghatage
P2860
P304
P356
10.1517/14656566.2016.1161027
P407
P577
2016-03-02T00:00:00Z